Spots Global Cancer Trial Database for incmga00012
Every month we try and update this database with for incmga00012 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Randomized Phase II Trial of a PD-1 Inhibitor INCMGA00012 as Consolidation Therapy After Definitive Concurrent Chemoradiotherapy(RHAPSODY) | NCT04494009 | Esophageal Canc... | INCMGA00012 | 19 Years - | Asan Medical Center | |
A Study of INCMGA00012 in Metastatic Merkel Cell Carcinoma (POD1UM-201) | NCT03599713 | Metastatic Merk... | Retifanlimab | 18 Years - | Incyte Corporation | |
A Study of INCMGA00012 in Squamous Carcinoma of the Anal Canal Following Platinum-Based Chemotherapy (POD1UM-202) | NCT03597295 | Squamous Cell C... | Retifanlimab | 18 Years - | Incyte Corporation | |
A Study of INCMGA00012 in Squamous Carcinoma of the Anal Canal Following Platinum-Based Chemotherapy (POD1UM-202) | NCT03597295 | Squamous Cell C... | Retifanlimab | 18 Years - | Incyte Corporation | |
A Study of INCMGA00012, INCB001158, and the Combination in Japanese Participants With Advanced Solid Tumors | NCT03910530 | Advanced Solid ... Metastatic Soli... | Retifanlimab INCB001158 Retifanlimab + ... | 18 Years - | Incyte Corporation | |
Neoadjuvant Chemotherapy and Retifanlimab in Patients With Selected Sarcomas (TORNADO) | NCT04968106 | Resectable Sarc... | Doxorubicin Ifosfamide INCMGA00012 | 18 Years - | Institut Bergonié | |
Phase Ib Trial of Multivalent Autophagosome Vaccine With or Without GITR Agonist, With Anti-PD-1 Immunotherapy in HNSCC | NCT04470024 | Cancer of the H... | INCAGN01876 INCMGA00012 DPV-001 | 18 Years - | Providence Health & Services | |
Neoadjuvant Chemotherapy and Retifanlimab in Patients With Selected Sarcomas (TORNADO) | NCT04968106 | Resectable Sarc... | Doxorubicin Ifosfamide INCMGA00012 | 18 Years - | Institut Bergonié | |
Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma | NCT04225039 | Glioblastoma | INCMGA00012 INCAGN01876 SRS Brain surgery | 18 Years - | University of Pennsylvania | |
A Study of INCMGA00012 in Metastatic Merkel Cell Carcinoma (POD1UM-201) | NCT03599713 | Metastatic Merk... | Retifanlimab | 18 Years - | Incyte Corporation | |
Study of Combination Therapy With INCMGA00012 (Anti-PD-1), INCAGN02385 (Anti-LAG-3), and INCAGN02390 (Anti-TIM-3) in Participants With Select Advanced Malignancies | NCT04370704 | Melanoma | INCAGN02385 INCAGN02390 INCMGA00012. | 18 Years - | Incyte Corporation | |
Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma | NCT04225039 | Glioblastoma | INCMGA00012 INCAGN01876 SRS Brain surgery | 18 Years - | University of Pennsylvania | |
Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma | NCT04225039 | Glioblastoma | INCMGA00012 INCAGN01876 SRS Brain surgery | 18 Years - | University of Pennsylvania |